Concert Genetics Earns Patent for Innovative Methods of Automating Genetic Test Coverage and Payment Accuracy Concert links 160,000 genetic tests to coverage criteria, automates accurate payment, and supports high-value clinical test ordering News provided by Share this article Share this article NASHVILLE, Tenn., June 9, 2021 /PRNewswire/ -- The U.S. Patent and Trademark Office has issued Concert Genetics patent US10,896,405B1 for innovative methods that enable real-time coverage determination and accurate reimbursement of genetic tests, the company announced today. As the patent describes, Concert's system converts health plan medical policies, typically text documents, into machine-readable criteria, and then links the criteria to every genetic test on the market. This system leverages Concert's platform for collecting, standardizing and organizing genetic test information, represented in patent